These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9424089)

  • 1. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals.
    Hertl M; Amagai M; Sundaram H; Stanley J; Ishii K; Katz SI
    J Invest Dermatol; 1998 Jan; 110(1):62-6. PubMed ID: 9424089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals.
    Hertl M; Karr RW; Amagai M; Katz SI
    J Invest Dermatol; 1998 Apr; 110(4):388-92. PubMed ID: 9540980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris.
    Veldman C; Höhne A; Dieckmann D; Schuler G; Hertl M
    J Immunol; 2004 May; 172(10):6468-75. PubMed ID: 15128839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris.
    Hertl M; Riechers R
    J Dermatol; 1999 Nov; 26(11):748-52. PubMed ID: 10635617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.
    Veldman C; Stauber A; Wassmuth R; Uter W; Schuler G; Hertl M
    J Immunol; 2003 Jan; 170(1):635-42. PubMed ID: 12496453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG reactivity to different desmoglein-3 ectodomains in pemphigus vulgaris: novel panels for assessing disease severity.
    Tavakolpour S; Noormohammadi Z; Daneshpazhooh M; Gholami A; Mahmoudi H
    Front Immunol; 2024; 15():1469937. PubMed ID: 39416775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.
    Hébert V; Novarino J; Maho-Vaillant M; Perals C; Calbo S; Golinski ML; Martinez F; Joly P; Fazilleau N
    Br J Dermatol; 2024 Sep; 191(4):605-615. PubMed ID: 38848544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.
    Lin MS; Swartz SJ; Lopez A; Ding X; Fernandez-Vina MA; Stastny P; Fairley JA; Diaz LA
    J Clin Invest; 1997 Jan; 99(1):31-40. PubMed ID: 9011573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
    Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
    Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.
    Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA
    J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease.
    Rizzo C; Fotino M; Zhang Y; Chow S; Spizuoco A; Sinha AA
    Clin Exp Dermatol; 2005 Sep; 30(5):535-40. PubMed ID: 16045688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus Vulgaris.
    Didona D; Scarsella L; Hudemann C; Volkmann K; Zimmer CL; Beckert B; Tikkanen R; Korff V; Kühn K; Wienzek-Lischka S; Bein G; Di Zenzo G; Böhme J; Cunha T; Solimani F; Pieper J; Juratli HA; Göbel M; Schmidt T; Borradori L; Yazdi AS; Sitaru C; Garn H; Eming R; Fleischer S; Hertl M
    J Invest Dermatol; 2024 Feb; 144(2):263-272.e8. PubMed ID: 37717934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of desmoglein-3 epitope region peptides as synthetic antigens: analysis of their in vitro T cell stimulating efficacy, cytotoxicity, stability, and their conformational features.
    Szabados H; Uray K; Majer Z; Silló P; Kárpáti S; Hudecz F; Bősze S
    J Pept Sci; 2015 Sep; 21(9):731-42. PubMed ID: 26250896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals.
    Veldman CM; Gebhard KL; Uter W; Wassmuth R; Grötzinger J; Schultz E; Hertl M
    J Immunol; 2004 Mar; 172(6):3883-92. PubMed ID: 15004196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor gene usage in desmoglein-3-specific T lymphocytes from patients with pemphigus vulgaris.
    Hacker-Foegen MK; Fairley JA; Lin MS
    J Invest Dermatol; 2003 Dec; 121(6):1365-72. PubMed ID: 14675184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.
    Schmidt T; Willenborg S; Hünig T; Deeg CA; Sonderstrup G; Hertl M; Eming R
    Exp Dermatol; 2016 Apr; 25(4):293-8. PubMed ID: 26661498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
    Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
    Aoyama Y; Owada MK; Kitajima Y
    Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.